The main aim of the trial was to determine whether drug treatment of mild hypertension (phase V diastolic pressure 90-109 mm Hg) reduced the rates of stroke, of death due to hypertension, and of coronary events in men and women aged 35-64 years. Subsidiary aims were: to compare the course of blood pressure in two groups, one taking bendrofluazide and one taking propranolol, and to compare the incidence of suspected adverse reactions to these two drugs. The study was single blind and based almost entirely in general practices; 17 354 patients were recruited, and 85 572 patient years of observation have accrued. Patients were randomly allocated at entry to take bendrofluazide or propranolol or placebo tablets. The primary results were as follows. The stroke rate was reduced on active treatment: 60 strokes occurred in the treated group and 109 in the placebo group, giving rates of 1.4 and 2.6 per 1000 patient years of observation respectively (p less than 0.01 on sequential analysis). Treatment made no difference, however, to the overall rates of coronary events: 222 events occurred on active treatment and 234 in the placebo group (5.2 and 5.5 per 1000 patient years respectively). The incidence of all cardiovascular events was reduced on active treatment: 286 events occurred in the treated group and 352 in the placebo group, giving rates of 6.7 and 8.2 per 1000 patient years respectively (p less than 0.05 on sequential analysis). For mortality from all causes treatment made no difference to the rates. There were 248 deaths in the treated group and 253 in the placebo group (rates 5.8 and 5.9 per 1000 patient years respectively). Several post hoc analyses of subgroup results were also performed but they require very cautious interpretation. The all cause mortality was reduced in men on active treatment (157 deaths versus 181 in the placebo group; 7.1 and 8.2 per 1000 patient years respectively) but increased in women on active treatment (91 deaths versus 72; 4.4 and 3.5 per 1000 patient years respectively). The difference between the sexes in their response to treatment was significant (p = 0.05). Comparison of the two active drugs showed that the reduction in stroke rate on bendrofluazide was greater than that on propranolol (p = 0.002). The stroke rate was reduced in both smokers and non-smokers taking bendrofluazide but only in non-smokers taking propranolol. This difference between the responses to the two drugs was significant (p = 0.03).(ABSTRACT TRUNCATED AT 400 WORDS)
[1]
S. Thompson,et al.
2 The Effect of Smoking on Blood Pressure in Mild Hypertensives, and on their Response to Antihypertensive Treatment
,
1984
.
[2]
TRIALS OF THE TREATMENT OF MILD HYPERTENSION An Interim Analysis
,
1982,
The Lancet.
[3]
S. Pocock.
Current issues in the design and interpretation of clinical trials.
,
1985,
British medical journal.
[4]
T. Wisniewski,et al.
THE ROLE OF BLOOD-PRESSURE CONTROL IN PREVENTING COMPLICATIONS OF HYPERTENSION.
,
1964,
Lancet.
[5]
W E Miall,et al.
Seasonal variation in arterial blood pressure.
,
1982,
British medical journal.
[6]
J. Abernethy.
The Australian therapeutic trial in mild hypertension.
,
1984,
Hypertension.
[7]
K. Aho,et al.
Cerebrovascular disease in the community: results of a WHO collaborative study.
,
1980,
Bulletin of the World Health Organization.
[8]
Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg.
,
1970,
JAMA.
[9]
G. A. Rose,et al.
A SPHYGMOMANOMETER FOR EPIDEMIOLOGISTS.
,
1964,
Lancet.
[10]
ADVERSE REACTIONS TO BENDROFLUAZIDE AND PROPRANOLOL FOR THE TREATMENT OF MILD HYPERTENSION Report of Medical Research Council Working Party on Mild to Moderate Hypertension
,
1981,
The Lancet.
[11]
A. Carter,et al.
Hypotensive therapy in stroke survivors.
,
1970,
Lancet.
[12]
M. Alderman,et al.
Management of the Hypertensive Patient: A Continuing Dilemma
,
1981,
Hypertension.
[13]
S. Pocock.
Group sequential methods in the design and analysis of clinical trials
,
1977
.
[14]
S. Chinn,et al.
Screening for Hypertension: Some Epidemiological Observations
,
1974,
British medical journal.
[15]
J. Garrow,et al.
Random-zero sphygmomanometer.
,
1970,
Lancet.
[16]
Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg.
,
1967,
JAMA.
[17]
R. Horwitz,et al.
Conflicting clinical trials and the uncertainty of treating mild hypertension.
,
1983,
The American journal of medicine.